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Large Femoral Heads Decrease the Incidence of
Dislocation After Total Hip Arthroplasty
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and the Large Articulation Study Group
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Base Hospitals, Ballarat, Victoria, Australia; Geelong Hospital, Geelong, Victoria, Australia; Maroondah and St. Vincent’s Hospitals,
Melbourne, Victoria, Australia; Royal Bournemouth Hospital, Bournemouth, England; Southampton General Hospital,
Southampton, England; and Ninewells Hospital, Dundee, Scotland
Background: The use of larger femoral heads has been proposed to reduce the risk of dislocation after total hip
arthroplasty, but there is a lack of evidence to support this proposal. The aim of this multicenter randomized
controlled trial was to determine whether the incidence of dislocation one year after total hip arthroplasty is sig-
nificantly lower in association with the use of a 36-mm femoral head articulation as compared with a 28-mm
articulation.
Methods: Six hundred and forty-four middle-aged and elderly patients undergoing primary or revision arthroplasty were
randomized intraoperatively to receive either a 36 or 28-mm metal femoral head on highly cross-linked polyethylene.
Patients who were at high risk of dislocation (including those with dementia and neuromuscular disease) and those
undergoing revision for the treatment of recurrent hip dislocation or infection were excluded. Patients were stratified
according to other potential risk factors for dislocation, including diagnosis and age. Diagnosis of hip dislocation required
confirmation by a physician and radiographic evidence of a dislocation.
Results: Overall, at one year of follow-up, hips with a 36-mm femoral head articulation had a significantly lower incidence
of dislocation than did those with a 28-mm articulation (1.3% [four of 299] compared with 5.4% [seventeen of 316];
difference, 4.1% [95% confidence interval, 1.2% to 7.2%]) when controlling for the type of procedure (primary or revision)
(p = 0.012). The incidence of dislocation following primary arthroplasty was also significantly lower for hips with a 36-mm
femoral head articulation than for those with a 28-mm articulation (0.8% [two of 258] compared with 4.4% [twelve of 275];
difference, 3.6% [95% confidence interval, 0.9% to 6.8%]) (p = 0.024). The incidence of dislocation following revision
arthroplasty was 4.9% (two of forty-one) for hips with a 36-mm articulation and 12.2% (five of forty-one) for hips with a
28-mm articulation; this difference was not significant with the relatively small sample size of the revision group (differ-
ence, 7.3% [95% confidence interval, 25.9% to 21.1%]) (p = 0.273).
Conclusions: Compared with a 28-mm femoral head articulation, a larger 36-mm articulation resulted in a significantly
decreased incidence of dislocation in the first year following primary total hip arthroplasty. However, before a 36-mm
metal-on-highly cross-linked polyethylene articulation is widely recommended, the incidence of late dislocation, wear,
periprosthetic osteolysis, and liner fracture should be established.
Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
Disclosure: One or more of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in
support of an aspect of this work. In addition, one or more of the authors, or his or her institution, has had a financial relationship, in the thirty-six months
prior to submission of this work, with an entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written
in this work. No author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to
influence what is written in this work. The complete Disclosures of Potential Conflicts of Interest submitted by authors are always provided with the
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islocation is the most common early complication
following total hip arthroplasty and is one of the most
common causes of early to intermediate-term revision
of primary total hip arthroplasty1,2.
The use of larger femoral heads has been proposed as
a means of reducing the risk of dislocation because larger-
diameter articulations have a relatively larger femoral head-to-
neck ratio, which increases hip motion before impingement
between components occurs3,4. Larger femoral head implants
require a greater amount of femoral head displacement before
dislocation occurs within a well-oriented acetabular compo-
nent4. However, concerns about polyethylene wear in larger-
diameter articulations, such as those involving 36 or 40-mm
femoral heads, have prevented their use with earlier genera-
tions of ultra-high molecular weight polyethylenes. The de-
velopment of highly cross-linked polyethylenes has now made
the use of larger articulations feasible in total hip arthroplasty,
given that the articulations involving the newer polyethylenes
have shown less wear than the previous generation of poly-
ethylenes in hip-simulator studies5,6 and randomized con-
trolled trials7-10.
Two nonrandomized cohort studies of primary arthro-
plasty in which larger (‡30-mm) articulations were compared
with 28-mm articulations suggested that increased femoral head
size may be associated with a decreased risk of dislocation11,12,
whereas other studies have not conclusively shown this finding13,14.
There are two important issues that need to be addressed
when determining the potential magnitude of the effect of
articulation size on the incidence of dislocation following hip
arthroplasty. First, the risk of dislocation may be influenced by
a number of other factors, including patient-related factors
(such as diagnosis14-16, age16,17, and sex15) and surgical technique.
Dislocation is more common in association with the posterior
approach11,17-19 and with a highly abducted acetabular compo-
nent orientation4 and is less common following soft-tissue
repair20,21. Second, the rate of hip dislocation is frequently
under-reported, primarily because of inadequate follow-up22.
As the number of data sources used to identify episodes of
dislocation increases, the capture rate increases significantly22.
The aim of the present study was to examine the hy-
pothesis that the incidence of dislocation at one year after total
hip arthroplasty is significantly lower in association with a
36-mm femoral head articulation than with a 28-mm articu-
lation. We undertook a randomized controlled trial in which a
number of factors that may influence the risk of hip dislocation
were controlled for by the study design and dislocation was
tracked with a number of different methods.
Materials and Methods
The results of this trial are reported in accordance with CONSORT (Consoli-dated Standards of Reporting Trials) 2010 guidelines23. The study was under-
taken as a multicenter, stratified, parallel-group randomized controlled trial
involving fourteen hospitals (see Appendix). Consultants, or fellows or residents
under their supervision, performed all procedures. The trial involved patients un-
dergoing primary or revision total hip arthroplasty who were intraoperatively
randomized to receive either a 28 or 36-mm femoral head articulation. Ethics
approval was received from the institutional review board of every participating
hospital. The trial is registered with the Australian New Zealand Clinical Trials
Registry (ACTRN12609000678291).
Every patient who was scheduled to be managed with total hip ar-
throplasty by one of the collaborating surgeons was screened for inclusion in
the trial. The reasons for, and the numbers of, preoperative exclusions are
shown in the Appendix.
Eligible patients provided written informed consent if they were willing
to participate in the trial. Patients were then stratified according to a number of
factors to increase the likelihood that possible risk factors for dislocation would
be distributed equally between patients randomized to a 36 or 28-mm femoral
head articulation. The stratification and randomization procedures are de-
scribed in detail in the Appendix.
The reasons for, and the numbers of, intraoperative exclusions for
patients undergoing primary and revision procedures are shown in the Ap-
pendix. The randomization envelope was opened in the operating room after all
exclusion criteria had been considered and it had been determined the patient
was to be included. The envelope was opened after the acetabular component
had been inserted and fixed with at least one screw but prior to the insertion of
the stem. The patient received either a 36 or 28-mm articulation, according to
the number in the envelope.
All arthroplasties were performed with use of uncemented acetabular
components, which comprised a cluster three-holed acetabular shell (Trilogy;
Zimmer, Warsaw, Indiana) fixed with one or two screws and a 10 elevated 36 or
28-mm-inner-diameter highly cross-linked polyethylene liner (Longevity; Zim-
mer). A cemented femoral stem was used for all primary arthroplasties (CPT;
Zimmer). Either a cemented femoral stem (CPT; Zimmer) or an uncemented
stem (ZMR; Zimmer) was used for revision arthroplasties. During the trial, the
taper of the CPT femoral stemwas changed from a 6 taper to a 12/14 taper by the
manufacturer. When possible, each surgeon completed his allocated randomi-
zation block before commencing with the use of the 12/14 taper.
All primary arthroplasties were performed through a posterior surgical
approach. Revision arthroplasties were performed through a posterior, trans-
femoral, or transtrochanteric approach. Repair of the capsule and external
rotators was performed routinely during primary arthroplasties and, when
possible, during revisions. The operative technique for insertion of the ace-
tabular component through a posterior approach included reliance mainly on
the alignment guide and confirmation by the surgeon’s judgment that the
component was reasonably positioned.
Determination of the incidence of hip dislocation required the use of a
number of different approaches to ensure that all dislocations were identified.
Prior to discharge, each patient was provided with a Dislocation Card, to be given
to any physician who subsequently treated the patient for dislocation, with in-
structions for that physician to notify the study coordinator of the dislocation.
Case notes were reviewed to check for inpatient episodes of postoperative dis-
location. The patient was then reviewed at six weeks to three months and at one
year, and any complications were noted. In addition, at each visit, the patient
completed a Hip Instability Questionnaire, which we had previously developed
and validated, and a Hospital Visit Questionnaire. The former included the item
‘‘hip came out of joint and was put back in by a physician,’’ whereas the latter
asked about all visits to an emergency room as well as any admissions. Dislocation
was defined as an event requiring reduction by a physician or surgeon for which
there was radiographic confirmation of a dislocation.
Patients, surgeons, and local study coordinators were not blinded to the
articulation size received.
Radiographs showing the initial hip dislocation in every patient were
assessed by one of the authors (D.W.H.) to determine the direction of dislo-
cation. The position of the femoral head relative to the acetabular cup on the
anteroposterior and lateral radiographs was used to determine the definite
direction of the dislocation. If the lateral radiograph was unavailable or inad-
equate, the anteroposterior pelvic radiograph was used. The prominence of the
lesser trochanter was compared to that of the contralateral side to determine the
rotation of the femur and thereby the probable direction of dislocation. If only
an anteroposterior hip radiograph was available, the prominence of the lesser
trochanter was used to determine the possible direction of dislocation.
1096
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 94-A d NUMBER 12 d JUNE 20, 2012
LARGE FEMORAL HEADS DECREASE THE INCIDENCE OF
DISLOCAT ION AFTER TOTAL HIP ARTHROPLASTY
The position of the acetabular component was assessed on the most
recent anteroposterior pelvic radiograph that had been made prior to the
dislocation. Inclination and anteversion of the acetabular component were
measured with use of EBRA (Ein-Bild-Roentgen-Analyse) (EBRA-CUP, Uni-
versity of Innsbruck, Innsbruck, Austria).
Statistical Analysis
With use of a power of 80% and a two-sided alpha of 0.05, initial sample size
estimates indicated that a total sample size of 650 patients would be required to
detect a significant and clinically important reduction in the incidence of dislo-
cation at one year from 8% in the 28-mm articulation group to 3% in the 36-mm
articulation group, if such a difference were to exist. A planned interim analysis by
an independent data-monitoring committee indicated adequate power for our
data, even allowing for a 5% rate of patient attrition, and therefore a decision was
made to stop recruitment after 644 patients had been randomized.
Poisson regression with, first, main effects of type of procedure (pri-
mary or revision arthroplasty) and articulation size (36 or 28 mm) and, second,
type of stem (CPT 12/14, CPT 6, or ZMR) and articulation size, was used to
examine whether the primary outcome measure, the incidence of dislocation
one year following total hip arthroplasty, was affected by articulation size. Log
of the total number of patients was used as offset. An analysis with use of a Cox
model was also undertaken to take into account the observed experience of
patients who were lost to follow-up within the first year, either through death,
revision, reoperation, or other reasons. Differences between means were as-
sessed with use of an independent-samples t test, and differences in proportions
were assessed with use of chi-square tests.
Source of Funding
The present study was funded by the National Health and Medical Research
Council of Australia and Zimmer. Funds were used for salary support of re-
search staff and for research-related activities. The funding sources had no role
in study design, data collection and analysis, the decision to publish, or the
preparation of the manuscript.
Results
Patients were recruited from September 2001 to June 2007.The numbers of patients who were assessed for eligibility,
who were excluded preoperatively or intraoperatively, and who
were randomized and included in the analyses are shown in
Figure 1. Three patients received the wrong articulation size.
These errors were due to breaches of protocol, with the enve-
lope being opened prior to confirmation of the availability of all
required components of the prosthesis and the required com-
ponent in the allocated size subsequently being identified as not
being available. These patients were included in the analysis ac-
cording to their allocated articulation size; none of these patients
had a dislocation. Seven (1.1%) of the 644 patients were lost to
follow-up at one year and were excluded from the analysis. An-
other twenty-two patients were also excluded, ten because they
died before the one-year follow-up without having a dislocation
and twelve because they had undergone revision arthroplasty or
reoperation, for reasons other than dislocation, that involved a
change of implant or potential damage to the hip as a result of the
surgery, which may have altered their risk of dislocation.
The incidence of dislocation at one year following hip
arthroplasty was significantly lower in patients with a 36-mm
femoral head articulation than in patients with a 28-mm ar-
ticulation. One year following primary or revision arthroplasty,
four (1.3%) of 299 hips with a 36-mm articulation and sev-
enteen (5.4%) of 316 hips with a 28-mm articulation had
dislocated (Table I). Controlling for the type of procedure
(primary or revision), the articulation size was significantly
related to dislocation (x2 = 6.4, p = 0.012), with a significantly
lower incidence of dislocation at one year in hips with a 36-mm
articulation than in those with a 28-mm articulation. The in-
cidence of dislocation at one year following primary hip ar-
throplasty was also significantly lower in hips with a 36-mm
articulation than in those with a 28-mm articulation (0.8%
[two of 258] compared with 4.4% [twelve of 275]) (x2 = 5.1,
p = 0.024). One year following revision arthroplasty, the
TABLE I Incidence of Dislocation One Year Following Total Hip Arthroplasty According to Type of Total Hip Arthroplasty or Type of Stem
and Articulation Size
Incidence of Dislocation








Hips in Group Percentage*
Difference Between
Groups* (%) P Value
Type of total
hip arthroplasty
All 4 of 299 1.3 (0.0 to 2.6) 17 of 316 5.4 (2.9 to 7.9) 4.1 (1.2 to 7.2) 0.012
Primary 2 of 258 0.8 (0.0 to 1.9) 12 of 275 4.4 (2.0 to 6.8) 3.6 (0.9 to 6.8) 0.024
Revision 2 of 41 4.9 (0.0 to 11.5) 5 of 41 12.2 (2.2 to 22.2) 7.3 (25.9 to 21.1) 0.273
Type of stem
CPT 12/14 2 of 163 1.2 (0.0 to 2.9) 8 of 178 4.5 (1.5 to 7.5) 3.3 (20.6 to 7.5) 0.101
CPT 6 1 of 117 0.9 (0.0 to 2.5) 7 of 120 5.8 (1.6 to 10.0) 4.9 (0.1 to 10.7) 0.072
ZMR 1 of 19 5.3 (0.0 to 15.3) 2 of 18 11.1 (0.0 to 25.6) 5.8 (215.1 to 28.0) 0.542
*The 95% confidence intervals are given in parentheses.
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incidence of dislocation was not significantly different between
hips with a 36-mm articulation and those with a 28-mm ar-
ticulation (4.9% [two of forty-one] compared with 12.2% [five
of forty-one]) (x2 = 1.2, p = 0.273), most likely because of an
insufficient number of revision procedures in the trial to
achieve adequate power for this comparison. A Cox model strat-
ified by the type of procedure (primary or revision) confirmed
a lower risk of dislocation for hips with a 36-mm articulation
during the first year following arthroplasty, taking into account
the observed experience of patients who were subsequently lost
to follow-up during the first year either through death, revi-
sion, reoperation, or another reason (p = 0.005). Controlling
for the type of femoral stem, articulation size was significantly
related to dislocation (x2 = 6.4, p = 0.012). However, there was
no significant difference in the incidence of dislocation be-
tween articulation sizes within any of the three stem types when
Fig. 1
CONSORT 2010 flow diagram. THA = total hip arthroplasty, FU = follow-up, pts = patients.
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considered individually, likely because of the smaller sample
sizes in the individual analyses (Table I).
Given the relatively small number of patients with larger
acetabular cup diameters, the relationship between femoral
head size, cup diameter, and dislocation risk could not be de-
termined in this study (Table II). However, three of the twenty-
one patients with a dislocation had a 28-mm articulation in an
acetabular cup with a diameter of at least 62 mm, representing
a radius mismatch of at least 17 mm, which previously was
identified as a risk factor for dislocation24.
In both the primary and revision arthroplasty groups, the
patients who were randomized to a 36-mm articulation were
TABLE II Relationship Between Outer Diameter of Acetabular Cup, Articulation Size, and Dislocation Within One Year Following Primary
and Revision Total Hip Arthroplasty
































50 28 26 0 1
52 58 1 68 3 4 1
54 48 66 4 1 2
56 58 54 5 5 2 1
58 34 1 27 8 6 1
60 15 22 8 1 7
62 8 8 5 1 5 1
64 5 3 3 7 1
66 0 1 3 6
68 1 0 1 1
70 1 2 1
72 2 0
74 0 1
*The outer diameter of the acetabular cup was unknown for three patients.
TABLE III Characteristics of Patients at Time of Primary Total Hip Arthroplasty According to Allocation to Articulation Size
36-mm Articulation (N = 273) 28-mm Articulation (N = 284) P Value Total (N = 557)
Female* (%) 56.0 (50.2 to 61.9) 61.3 (55.6 to 66.9) 0.212 58.7 (54.6 to 62.8)
Age (yr)
Mean* 72.3 (71.5 to 73.0) 72.3 (71.6 to 73.1) 0.891 72.3 (71.8 to 72.8)
Range 59 to 93 60 to 92 59 to 93
BMI†
Mean* 28.0 (27.4 to 28.7) 28.4 (27.8 to 29.0) 0.371 28.2 (27.8 to 28.7)
Range 16.7 to 44.0 18.8 to 51.5 16.7 to 51.5
Primary or secondary
osteoarthritis*‡ (%)
96.3 (94.1 to 98.6) 95.4 (93.0 to 97.9) 0.588 95.9 (94.2 to 97.5)
Type of stem* (%) 0.704
CPT 12/14 59.3 (53.5 to 65.2) 60.9 (55.2 to 66.6) 60.1 (56.1 to 64.2)
CPT 6 40.7 (34.8 to 46.5) 39.1 (33.4 to 44.8) 39.9 (35.8 to 43.9)
*The 95% confidence intervals are given in parentheses. †Data on BMI (body mass index) were available for a total of 484 patients (237 with a
36-mm articulation and 247 with a 28-mm articulation).‡Primary or secondary osteoarthritis without a previous fracture, traumatic dislocation, or
surgery to the index hip.
1099
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 94-A d NUMBER 12 d JUNE 20, 2012
LARGE FEMORAL HEADS DECREASE THE INCIDENCE OF
DISLOCAT ION AFTER TOTAL HIP ARTHROPLASTY
similar to those who were randomized to a 28-mm articulation
(Tables III and IV).
Overall, seventeen (81%) of the twenty-one hips that
dislocated within one year after primary or revision arthroplasty
had a 28-mm articulation (Table V). The majority (nine) of the
fourteen hips that dislocated after primary arthroplasty did so
within thirty days after surgery, whereas hips that dislocated after
revision arthroplasty showed a tendency to dislocate later. Ap-
proximately one-third of dislocating hips redislocated. Within
the first year after hip arthroplasty, revision surgery for the
TABLE IV Characteristics of Patients at Time of Revision Total Hip Arthroplasty According to Allocation to Articulation Size
36-mm Articulation(N = 42) 28-mm Articulation(N = 45) P Value Total (N = 87)
Female* (%) 45.2 (30.2 to 60.3) 48.9 (34.3 to 63.5) 0.733 47.1 (36.6 to 57.6)
Age (yr)
Mean* 75.2 (72.7 to 77.7) 73.8 (71.5 to 76.0) 0.384 74.4 (72.8 to 76.1)
Range 54 to 89 56 to 87 54 to 89
BMI†
Mean* 28.9 (27.3 to 30.5) 27.8 (26.4 to 29.2) 0.304 28.3 (27.3 to 29.4)
Range 21.6 to 44.6 21.8 to 42.9 21.6 to 44.6
Type of revision* (%) 0.591
Revision of hemiarthroplasty 11.9 (2.1 to 21.7) 17.8 (6.6 to 29.0) 14.9 (7.5 to 22.4)
1st revision of total hip
arthroplasty
78.6 (66.2 to 91.0) 68.9 (55.4 to 82.4) 73.6 (64.3 to 82.8)
‡2nd revision of total hip
arthroplasty
9.5 (0.7 to 18.4) 13.3 (3.4 to 23.3) 11.5 (4.8 to 18.2)
Type of stem* (%) 0.880
CPT 12/14 26.2 (12.9 to 39.5) 31.1 (17.6 to 44.6) 28.7 (19.2 to 38.2)
CPT 6 28.6 (14.9 to 42.2) 26.7 (13.8 to 39.6) 27.6 (18.2 to 37.0)
ZMR 45.2 (30.2 to 60.3) 42.2 (27.8 to 56.7) 43.7 (33.3 to 54.1)
*The 95% confidence intervals are given in parentheses. †Data on BMI (body mass index) were available for a total of eighty-one patients (thirty-
nine with a 36-mm articulation and forty-two with a 28-mm articulation).
TABLE V Characteristics of Patients Who Had Hip Dislocation Within One Year After Primary or Revision Total Hip Arthroplasty
Primary Arthroplasty (N = 14) Revision Arthroplasty (N = 7)
36-mm:28-mm articulation (no. of hips) 2:12 2:5
Female:male ratio (no. of hips) 9*:5* 3*:4*
Age† (yr) 73 (62 to 84) 76 (61 to 83)
BMI† 29 (20 to 39) 26 (23 to 34)
Primary or secondary osteoarthritis‡ 12* NA§
Type of revision (revision of hemiarthroplasty:1st revision of
total hip arthroplasty:‡2nd revision of total hip arthroplasty)
(no. of hips)
NA§ 1:4#:2
Stem type (CPT 6:CPT 12/14:ZMR) (no. of hips) 5:9#:NA§ 3*:1:3*
1st dislocation (£10 days:11 to 30 days:31 to 100
days:>100 days postop.) (no. of hips)
4:5*:3*:2 1:1:4*:1*
>1 dislocation (no. of hips) 5* 3
Revised because of recurrent dislocation (no. of hips) 2* 3
Closed reduction of 1st dislocation (no. of hips) 13# 6#
*Includes one patient with a 36-mm articulation. †The values are given as the median, with the range in parentheses. ‡Primary or secondary
osteoarthritis without a previous fracture, traumatic dislocation, or surgery on the index hip. §NA = not applicable. #Includes two patients with a
36-mm articulation.
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treatment of recurrent dislocation was required in two of the
fourteen hips that dislocated after primary arthroplasty and
three of the seven that dislocated after revision arthroplasty;
another hip that had dislocated after primary arthroplasty was
revised because of failed closed reduction of the dislocation.
Of the fourteen first dislocations that occurred after pri-
mary arthroplasty, three were classified as definitely posterior,
seven were classified as probably posterior, one was classified as
possibly posterior, and three were classified as probably anterior.
Of the seven first dislocations that occurred after revision ar-
throplasty, two were classified as definitely posterior, two were
classified as probably posterior, two were classified as anterior,
and one was classified as having an indeterminate direction.
The median inclinations of the acetabular components
used for primary and revision total hip arthroplasties with a
28-mm articulation that subsequently dislocated were 44 (range,
34 to 52) and 45 (range, 41 to 51), respectively, and the
median anteversions were 15 (range, 7 to 32) and 16 (range,
10 to 22), respectively. The two hips with a 36-mm articulation
that dislocated after a primary procedure both had an inclination
of 48 and anteversions of 5 and 7. The two hips with a 36-mm
articulation that dislocated after a revision procedure both had
an inclination of 43 and an anteversion of 10.
Discussion
The purpose of the present randomized controlled trial was todetermine whether a larger (36-mm) femoral head articu-
lation significantly reduced the incidence of dislocationwithin the
first year following total hip arthroplasty in comparison with a
28-mm articulation. The results of this trial indicated that the
incidence of dislocationwithin one year after primary arthroplasty
was five times lower in patients with a 36-mm articulation (0.8%)
than in those with a 28-mm articulation (4.4%); this difference
was both clinically important and statistically significant.
The use of larger femoral head implants for total hip
arthroplasty has been increasing during the last decade25-27,
largely on the basis of the premise that larger articulations are
efficacious for preventing dislocations. Our trial showed that a
larger articulation significantly reduced the risk of dislocation
following primary arthroplasty. The number of patients un-
dergoing revision arthroplasty as part of the trial was relatively
small, and therefore the difference in the incidence of dislo-
cation between the 36 and 28-mm articulations did not attain
significance. It should be noted, however, that initial sample
size calculations estimated the total number of patients re-
quired for an analysis of the effect of articulation size on the
incidence of dislocation rather than the numbers required to
examine the effects in the primary and revision arthroplasty
groups independently.
Our conclusion that a larger articulation decreased the
risk of dislocation following total hip arthroplasty supports the
findings of two cohort studies11,12 as well as those of two registry
studies that showed a decreased risk of revision for dislocation
after total hip arthroplasty with larger articulations18,28.
Although we have been able to determine the short-term
benefits of a larger, 36-mm metal-on-polyethylene articulation
in total hip arthroplasty, specifically in terms of decreasing the
incidence of dislocation up to one year following arthroplasty,
what is best at one year may not be best at ten years. This needs
to be emphasized because the use of a larger articulation in a
metal-on-polyethylene bearing is not without potential risks.
In an acetabular component of a given outer diameter, a 36-mm
liner will of necessity be thinner than a 28-mm liner, particu-
larly at the rim. The polyethylene thickness for a 36-mm liner
in an acetabular component with an outer diameter of 50 mm
is 6.7 mm at the pole and 5.8 mm at 45. This may increase wear
or even wear-through compared with the smaller-diameter
liner, although the findings of simulator studies have been
encouraging29,30. However, even if cross-linking improves wear
resistance, the mechanical properties of highly cross-linked
polyethylenes are reduced, leading to increased fracture po-
tential of such liners, irrespective of the inner diameter31,32.
Wear has been used as a surrogate measure of osteolysis
with previous generations of polyethylene implants. Given the
same rate of linear wear, volumetric wear will be greater in a
larger articulation. However, the relationship between head
penetration, volumetric wear of highly cross-linked polyeth-
ylene, and osteolysis is not yet well defined33.
The major strength of our randomized trial was the ability
to control for other variables that may affect the risk of dislo-
cation. We chose to exclude patients who had certain charac-
teristics that, although not common, could significantly increase
the risk of dislocation and could affect the results if not equally
distributed across the 36 and 28-mm articulation groups. Im-
portantly, patients who were to undergo revision were excluded
if revisionwas being undertaken because of recurrent dislocation
or infection. Patients were stratified by other factors that were
also considered possible risk factors for dislocation.
One limitation of our study is that seven (1.1%) of the
644 patients were lost to follow-up at one year and that six of
these patients had received a 36-mm articulation. For patients
who had been lost to follow-up, reviews of hospital records
and, when available, local physician records suggested that no
dislocations had occurred. However, as it could not be con-
firmed that no dislocations had occurred, the patients were
treated as having been lost to follow-up and were excluded
from the analysis.
In our randomized trial, the incidence of dislocation in
the first year after primary total hip arthroplasty with a 28-mm
articulation was 4.4%. Although this figure is at the upper end
of the range of incidences reported in large cohort studies, two
factors are likely to have influenced this finding. First, the in-
cidence of dislocation is known to be higher in association with
a posterior approach11,17-19. Second, the reported incidence is
higher when patients are routinely followed and when the
number of methods used to track dislocation increases22.
In conclusion, the present randomized trial showed that
a larger articulation significantly reduced the incidence of
dislocation in the first year after total hip arthroplasty with a
metal-on-highly cross-linked polyethylene articulation. It must
be emphasized that before a 36-mm metal-on-highly cross-
linked polyethylene articulation is widely recommended,
1101
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 94-A d NUMBER 12 d JUNE 20, 2012
LARGE FEMORAL HEADS DECREASE THE INCIDENCE OF
DISLOCAT ION AFTER TOTAL HIP ARTHROPLASTY
particularly in younger patients or those at lower risk of dis-
location, the incidence of late dislocation, wear, periprosthetic
osteolysis, and acetabular liner fracture needs to be established.
Appendix
Tables showing a description of the study centers and the
reasons for the preoperative and intraoperative exclusion
of patients from the study and additional paragraphs describing
the stratification and radomization preocedures are available
with the online version of this article as a data supplement at
jbjs.org. n
NOTE: The Large Articulation Study Group: D. Howie, O. Holubowycz (Chief Investigators). Royal
Adelaide Hospital: D. Howie, B. Allen, S. Brumby, M. Chehade, R. Clarnette, A. Comley, A. Mintz,
R.Montgomery, A. Pohl, T. Savvoulidis, B. Solomon, J. van Essen (surgeons), A. Standen (Local Study
Coordinator [LSC]). St. Andrew’s Hospital: D. Howie (surgeon), M. Bennier (LSC). Glenelg Hospital:
D. Howie (surgeon), M. Bennier (LSC). Modbury Hospital: S. Brumby (surgeon), S. Pannach (LSC).
Whyalla Hospital: T. Savvoulidis (surgeon). Royal North Shore Hospital: A. Ellis, S. Ruff (surgeons),
E. Cole (LSC). St. John of God and Ballarat Base Hospitals: J. Nelson (surgeon), C. Gear (LSC).
Geelong Hospital: S. Williams, R. Angliss (surgeons), S. Beattie, U. Farago, C. Gleeson,
A. Vanderveen (LSCs). St. Vincent’s Hospital Melbourne: A. Dunin, B. Love (surgeons),
M. Dowsey, M. Farley (LSCs). Maroondah Hospital: D. Booth, P. Gard (surgeons), J. Walsh (LSC).
Royal Bournemouth Hospital: R. Middleton (UK surgeon coordinator), T. Wainwright, S. Sargeant
(LSCs). Southampton General Hospital: D. Dunlop, J. Latham (surgeons), A. Wakefield (LSC).
Ninewells Hospital: B. Clift, D. Rowley (surgeons), L. Johnston, L. McCormack (LSCs).
The authors gratefully acknowledge Dr. Nancy Briggs, from the Discipline of Public Health at the
University of Adelaide, for undertaking statistical analysis of the data; Mr. Stuart Callary, from the
Department of Orthopaedics and Trauma at the Royal Adelaide Hospital, for assessing acetabular
component position; and the Joint Replacement Nurses at the Royal Adelaide Hospital for as-
sistance with the trial.
Donald W. Howie, MBBS, FRACS, PhD
Oksana T. Holubowycz, PhD, MPH
Department of Orthopaedics and Trauma,
Level 4, Bice Building, North Terrace,
Royal Adelaide Hospital, Adelaide, SA 5000, Australia.
Email address for O.T. Holubowycz: oksana.holubowycz@health.sa.gov.au
Robert Middleton, MBBChir, MA, FRCS(Orth)
34 Alington Road, Poole BH148LZ, England
References
1. Australian Orthopaedic Association. National Joint Replacement Registry. Annual
report. Adelaide: AOA; 2010.
2. National Joint Registry for England and Wales. 5th annual report. National Joint
Registry; 2008.
3. He RX, Yan SG, Wu LD, Wang XH, Dai XS. Position of the prosthesis and the
incidence of dislocation following total hip replacement. Chin Med J (Engl). 2007;
120:1140-4.
4. Crowninshield RD, Maloney WJ, Wentz DH, Humphrey SM, Blanchard CR. Bio-
mechanics of large femoral heads: what they do and don’t do. Clin Orthop Relat Res.
2004;429:102-7.
5. McKellop H, Shen FW, Lu B, Campbell P, Salovey R. Effect of sterilization method
and other modifications on the wear resistance of acetabular cupsmade of ultra-high
molecular weight polyethylene. A hip-simulator study. J Bone Joint Surg Am.
2000;82:1708-25.
6. D’Lima DD, Hermida JC, Chen PC, Colwell CW Jr. Polyethylene cross-linking by
two different methods reduces acetabular liner wear in a hip joint wear simulator.
J Orthop Res. 2003;21:761-6.
7. Thomas GER, Simpson DJ, Mehmood S, Taylor A, McLardy-Smith P, Gill HS,
Murray DW, Glyn-Jones S. The seven-year wear of highly cross-linked
polyethylene in total hip arthroplasty: a double-blind, randomized controlled
trial using radiostereometric analysis. J Bone Joint Surg Am. 2011;93:
716-22.
8. McCalden RW, MacDonald SJ, Rorabeck CH, Bourne RB, Chess DG, Charron KD.
Wear rate of highly cross-linked polyethylene in total hip arthroplasty. A randomized
controlled trial. J Bone Joint Surg Am. 2009;91:773-82.
9. Digas G, Ka¨rrholm J, Thanner J, Herberts P. 5-year experience of highly cross-
linked polyethylene in cemented and uncemented sockets: two randomized studies
using radiostereometric analysis. Acta Orthop. 2007;78:746-54.
10. Mutimer J, Devane PA, Adams K, Horne JG. Highly crosslinked polyethylene
reduces wear in total hip arthroplasty at 5 years. Clin Orthop Relat Res. 2010:
468;3228-33.
11. Berry DJ, von Knoch M, Schleck CD, Harmsen WS. Effect of femoral head di-
ameter and operative approach on risk of dislocation after primary total hip arthro-
plasty. J Bone Joint Surg Am. 2005;87:2456-63.
12. Amlie E, Høvik Ø, Reikerås O. Dislocation after total hip arthroplasty with 28 and
32-mm femoral head. J Orthop Traumatol. 2010,11:111-5.
13. Peters CL, McPherson E, Jackson JD, Erickson JA. Reduction in early dislocation
rate with large-diameter femoral heads in primary total hip arthroplasty. J Arthro-
plasty. 2007;22(6 Suppl. 2):140-4.
14. Khatod M, Barber T, Paxton E, Namba R, Fithian D. An analysis of the risk of hip
dislocation with a contemporary total joint registry. Clin Orthop Relat Res. 2006;
447:19-23.
15. Woo RY, Morrey BF. Dislocations after total hip arthroplasty. J Bone Joint Surg
Am. 1982;64:1295-306.
16. Meek RM, Allan DB, McPhillips G, Kerr L, Howie CR. Epidemiology of dislocation
after total hip arthroplasty. Clin Orthop Relat Res. 2006;447:9-18.
17. Morrey BF. Instability after total hip arthroplasty. Orthop Clin North Am. 1992;
23:237-48.
18. Bystro¨m S, Espehaug B, Furnes O, Havelin LI; Norwegian Arthroplasty Register.
Femoral head size is a risk factor for total hip luxation: a study of 42,987 primary hip
arthroplasties from the Norwegian Arthroplasty Register. Acta Orthop Scand.
2003;74:514-24.
19. Blom AW, Rogers M, Taylor AH, Pattison G, Whitehouse S, Bannister GC. Dis-
location following total hip replacement: the Avon Orthopaedic Centre experience.
Ann R Coll Surg Engl. 2008;90:658-62.
20. van Stralen GM, Struben PJ, van Loon CJ. The incidence of dislocation after
primary total hip arthroplasty using posterior approach with posterior soft-tissue
repair. Arch Orthop Trauma Surg. 2003;123:219-22.
21. Tsai SJ, Wang CT, Jiang CC. The effect of posterior capsule repair upon post-
operative hip dislocation following primary total hip arthroplasty. BMC Musculo-
skeletal Disord. 2008;9:29.
22. Hedlundh U, Ahnfelt L, Fredin H. Incidence of dislocation after hip arthroplasty.
Comparison of different registration methods in 408 cases. Acta Orthop Scand.
1992;63:403-6.
23. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ,
Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration:
updated guidelines for reporting parallel group randomised trials. BMJ. 2010;
340:c869.
24. Kelley SS, Lachiewicz PF, Hickman JM, Paterno SM. Relationship of femoral
head and acetabular size to the prevalence of dislocation. Clin Orthop Relat Res.
1998;355:163-70.
25. National Joint Registry for England and Wales. 6th Annual Report. National Joint
Registry; 2009.
26. Australian Orthopaedic Association. National Joint Replacement Registry.
Annual report. Adelaide: Australian Orthopaedic Association; 2003.
27. Australian Orthopaedic Association National Joint Replacement Registry.
Annual Report. Adelaide: AOA; 2008.
28. Conroy JL, Whitehouse SL, Graves SE, Pratt NL, Ryan P, Crawford RW. Risk
factors for revision for early dislocation in total hip arthroplasty. J Arthroplasty.
2008;23:867-72.
29. Muratoglu OK, Bragdon CR, O’Connor D, Perinchief RS, Estok DM 2nd, Jasty M,
Harris WH. Larger diameter femoral heads used in conjunction with a highly cross-
linked ultra-high molecular weight polyethylene: a new concept. J Arthroplasty.
2001;16(8 Suppl 1):24-30.
30. Hermida JC, Bergula A, Chen P, Colwell CW Jr, D’Lima DD. Comparison of the
wear rates of twenty-eight and thirty-two-millimeter femoral heads on cross-linked
polyethylene acetabular cups in a wear simulator. J Bone Joint Surg Am. 2003;
85:2325-31.
31. Collier JP, Currier BH, Kennedy FE, Currier JH, Timmins GS, Jackson SK, Brewer
RL. Comparison of cross-linked polyethylene materials for orthopaedic applications.
Clin Orthop Relat Res. 2003;414:289-304.
32. Ries MD, Pruitt L. Effect of cross-linking on the microstructure and mechanical
properties of ultra-high molecular weight polyethylene. Clin Orthop Relat Res.
2005;440:149-56.
33. Mall NA, Nunley RM, Zhu JJ, Maloney WJ, Barrack RL, Clohisy JC. The incidence
of acetabular osteolysis in young patients with conventional versus highly cross-
linked polyethylene. Clin Orthop Relat Res. 2011;469:372-81.
1102
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 94-A d NUMBER 12 d JUNE 20, 2012
LARGE FEMORAL HEADS DECREASE THE INCIDENCE OF
DISLOCAT ION AFTER TOTAL HIP ARTHROPLASTY
Howie eAppendix            Page 1 of 5 
 
TABLE E-1 Description of Study Centers 
   
No. of Patients 
(No. of Hips That 
Dislocated) 
Hospital Type of Hospital 
No. of 
Surgeons Primary Revision 
Australia     
Royal Adelaide Teaching, tertiary 
referral 
12 135 (5)* 33 (3) 
St. Andrew’s, Adelaide Metropolitan 1† 28 1 
Glenelg, Adelaide Metropolitan 1† 5 0 
Modbury, Adelaide Teaching, 
metropolitan 
1† 10 0 
Whyalla, Whyalla Non-metropolitan 1† 5 0 




2 58 (1) 0 
St. John of God, Ballarat Non-metropolitan 1 45 (1) 1 
Ballarat Base, Ballarat Teaching, non-
metropolitan 
1† 8 0 
Geelong, Geelong Teaching, non-
metropolitan 
2 15 (1) 0 
Maroondah, Melbourne Metropolitan 2 11 0 
St. Vincent’s, Melbourne Teaching, tertiary 
referral 
2 8 3 (1) 
England     
Royal Bournemouth Teaching, tertiary 
referral 
1 124 (2) 43 (3) 
Southampton General Teaching, tertiary 
referral 
2 79 (3) 0 
Scotland     
Ninewells, Dundee Teaching, tertiary 
referral 
2 26 (1) 6 
All 14 hospitals  26 557 (14) 87 (7) 
*A different surgeon operated on each of the five patients. †Surgeon also in trial at other listed hospital. 
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TABLE E-2 Numbers of Patients Excluded Preoperatively According to Exclusion Criteria, by Type of 
Total Hip Arthroplasty 








Too young (<60 years old for primary procedures†; <50 years old for 
revision procedures) 
559 20 
Simultaneous bilateral total hip arthroplasty 2 0 
Contralateral hip already in trial 50 6 
Previous infection in hip 11 7 
Diagnosis other than osteoarthritis, rheumatoid arthritis, inflammatory 
arthritis, or previous fracture/dislocation/surgery involving the hip 
13 NA 
Revision for hip instability NA 34 
Revision for infection NA 17 
Second stage of 2-stage revision or previous excision arthroplasty NA 15 
Not revision of hemiarthroplasty or conventional total hip arthroplasty NA 5 
Planned prosthesis   
Not Trilogy/CPT 455‡ NA 
Not Trilogy/CPT or ZMR NA 50 
Planned approach   
Not posterior 4 NA 
Not posterior, transtrochanteric, or transfemoral NA 0 
Intention to return to sports involving running or contact sports 0 0 
Abnormal acetabulum 29 NA 
Abnormal abductor mechanism 4 8 
Likely postoperative leg-length inequality of >5 cm 1 1 
Neuromuscular disease affecting hip 15 1 
Primary or metastatic tumor involving index hip 10 1 
Unable to provide informed consent 
(insufficient ability to communicate in English language/cognitive 
disorder/psychiatric illness) 
73 15 
Unable to complete follow-up 
(life expectancy <2 years/unable to complete English-language 
questionnaires/unable to return easily) 
27 17 
Total 1253 197 
*Patients were excluded in a hierarchical manner, with only the first listed relevant exclusion criterion 
being recorded. NA = not applicable. †All Australian surgeons excluded patients less than sixty-five 
years old, one surgeon from the UK excluded patients less than seventy years old, and the other 
surgeons from the UK excluded patients less than sixty years old. ‡In one collaborating center, elderly, 
less-active patients received a cemented cup for cost reasons. 
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TABLE E-3 Numbers of Patients Excluded Intraoperatively According to Exclusion Criteria, by Type of 
Total Hip Arthroplasty 
 No. of Patients Excluded* 
Exclusion Criterion 
Primary Total Hip 
Arthroplasty 
Revision Total Hip 
Arthroplasty 
Surgical approach   
Not posterior   2 NA 
Not posterior, transtrochanteric, or transfemoral NA 0 
Infection involving joint 0 0 
Abnormal acetabulum 8 NA 
Abnormal abductor mechanism 4 5 
CPT or ZMR stem not inserted 2 11 
Acetabular component not Trilogy with an outer 
diameter of ≥50 mm and fixed with at least one screw 
8 14 
Trial 28-mm liner not in place or trial stem not reduced NA 2 
Standard 28-mm or offset 36-mm liner not appropriate, 
or plan to use a long-neck skirted head  
1 0 
28 and 36-mm heads and liners for inserted shell not in 
operating room 
9 1 
Total  34 33 
*Patients were excluded in a hierarchical manner, with only the first listed relevant exclusion criterion 
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Appendix E-1 
Prior to randomization, patients undergoing primary arthroplasty were stratified by 
surgeon, age (sixty to seventy-four years; seventy-five years or more), and diagnosis 
(previous fracture, traumatic dislocation, or surgery involving the index hip, irrespective 
of diagnosis; osteoarthritis without previous fracture, traumatic dislocation, or surgery; 
rheumatoid arthritis or inflammatory arthritis without previous fracture, traumatic 
dislocation, or surgery). If a patient had a diagnosis of osteoarthritis without previous 
fracture, traumatic dislocation, or surgery and was under seventy-five years old, he or she 
was also stratified by Charnley grade (A or B; C) and, if the patient was classified as 
Charnley A or B, he or she was further stratified by sex, resulting in eight strata per 
surgeon. Allocation of randomization sequences, with an allocation ratio of 1:1, was 
undertaken in block sizes of two, four, six, or eight on the basis of the anticipated 
prevalence of patients in each stratum, with larger block sizes being used for initial 
allocations. All ninety-eight possible allocation sequences were listed numerically, and 
each specific sequence was then chosen with random-number generation in Excel, 
without repetition, with use of the RANDBETWEEN command to choose from the 
required block size (block of two, sequences one to two; block of four, sequences three to 
eight, etc.). Each surgeon’s unique randomization protocol initially allowed for forty-
eight patients over the eight strata, with further allocations added subsequently if 
required. Sealed envelopes containing a folded piece of cardboard with either a “36” or 
“28” sticker were prepared in accordance with each consecutive allocation of a 36 or 28-
mm articulation, over consecutive strata. Each envelope was then assigned a number with 
use of RANUNI, an SAS software random-number function (SAS Institute, Cary, North 
Carolina) programmed to generate forty-eight random numbers without replacement. The 
local study coordinator was notified of the next envelope number in the appropriate 
stratum, and that envelope was taken to the operating room. 
Patients undergoing revision arthroplasty were stratified first according to the type of 
stem (cemented [CPT; Zimmer, Warsaw, Indiana] or uncemented [ZMR; Zimmer]) and 
then by whether they were undergoing revision of a hemi-arthroplasty or, if undergoing 
revision of a total hip arthroplasty, the number of previous revisions (first revision, 
second revision, or third revision [or greater]), resulting in four strata in each of the two 
randomization protocols, one being for revision with a CPT stem and the other for a ZMR 
stem. The randomization process for revision arthroplasty was the same as that described 
above for primary arthroplasty, except that each patient was allocated an envelope 
number from both the CPT and ZMR protocols, given that the decision to use a cemented 
or uncemented stem is occasionally made intra-operatively. 
The Study Epidemiologist (O.T.H.) was responsible for every aspect of stratification 
and randomization. Participating surgeons and local study coordinators, who were 
responsible for enrolling patients, were not aware of the stratification and randomization 
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protocols. Local coordinators were advised by email of the allocated envelope number for 
each patient and ensured that this envelope was available in the operating room at the 
time of surgery. Envelopes allocated to patients who were excluded intraoperatively were 
returned unopened, to be reused when appropriate. 
